National trends of outcomes in transcatheter aortic valve replacement (TAVR) through transapical versus endovascular approach: From the National Inpatient Sample (NIS).

[1]  M. Barbanti,et al.  How to Avoid Coronary Occlusion During TAVR Valve-in-Valve Procedures , 2019, Front. Cardiovasc. Med..

[2]  D. Cohen,et al.  Transcarotid Versus Transapical and Transaortic Access for Transcatheter Aortic Valve Replacement. , 2019, The Annals of thoracic surgery.

[3]  M. Niemelä,et al.  Comparison of Outcomes After Transcatheter Aortic Valve Replacement vs Surgical Aortic Valve Replacement Among Patients With Aortic Stenosis at Low Operative Risk , 2019, JAMA network open.

[4]  J. Leipsic,et al.  Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[5]  Andrew S. Mugglin,et al.  Transcatheter Aortic‐Valve Replacement with a Self‐Expanding Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[6]  S. Mattke,et al.  TEMPORAL TRENDS IN 30-DAY AND 1-YEAR MORTALITY RATES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: A SYSTEMATIC REVIEW AND META-REGRESSION ANALYSIS , 2019, Journal of the American College of Cardiology.

[7]  A. Adejumo,et al.  Among inpatients, ischemic bowel disease predisposes to Clostridium difficile infection with concomitant higher mortality and worse outcomes , 2019, European journal of gastroenterology & hepatology.

[8]  Deepak L. Bhatt,et al.  Trends in Inpatient Complications After Transcatheter and Surgical Aortic Valve Replacement in the Transcatheter Aortic Valve Replacement Era , 2018, Circulation. Cardiovascular interventions.

[9]  R. Steeds,et al.  Patient screening for early detection of aortic stenosis (AS)-review of current practice and future perspectives. , 2018, Journal of thoracic disease.

[10]  R. Atoui,et al.  Non-transfemoral access sites for transcatheter aortic valve replacement. , 2018, Journal of thoracic disease.

[11]  A. Rodday,et al.  Risk factors for length of stay and charge per day differ between older and younger hospitalized patients with AML , 2018, Cancer medicine.

[12]  V. Nkomo,et al.  Management of Patients With Aortic Valve Stenosis , 2018, Mayo Clinic proceedings.

[13]  I. Koniari,et al.  Transcatheter aortic valve replacement and stroke: a comprehensive review , 2018, Journal of geriatric cardiology : JGC.

[14]  G. Hahalis,et al.  TAVR in 2017―What we know? What to expect? , 2018, Journal of geriatric cardiology : JGC.

[15]  R. Khouzam,et al.  Permanent pacemaker insertion in patients with conduction abnormalities post transcatheter aortic valve replacement: a review and proposed guidelines. , 2018, Annals of translational medicine.

[16]  N. Curzen,et al.  Transcatheter aortic valve implantation: where are we now? , 2017, Future cardiology.

[17]  M. R. Sardar,et al.  Vascular complications of transcatheter aortic valve replacement: A concise literature review , 2017, World journal of cardiology.

[18]  M. Mack,et al.  If TAVR Cannot Be Transfemoral, Then What? , 2016, JACC. Cardiovascular interventions.

[19]  M. Mack,et al.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.

[20]  H. Jilaihawi,et al.  Causes of Death Following Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis , 2015, Journal of the American Heart Association.

[21]  Assaf Bash,et al.  Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description , 2002, Circulation.

[22]  Roger Newson,et al.  Parameters behind “Nonparametric” Statistics: Kendall's tau, Somers’ D and Median Differences , 2002 .